Introduction to Pediatrics Flashcards

1
Q

Role of the pediatric pharmacist

A

Drug selection and use
Monitoring of effectiveness and toxicity
Prevention of medication errors
Patient/caregiver education
Contributions to knowledge through research
Knowledge of pediatric disease states and drug therapy
Skills to apply knowledge to practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most common chronic medical conditions in pediatrics

A

Asthma and ADHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Signs of pain

A

Increased respiratory rate
Increased heart rate
Oxygen desaturations
*Hypothermia - indicates sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Scales to measure pain

A

<4 yo = Neonate Infant Pain Scale (NIPS) or Face, Legs, Activity, Cry, Consolability (FLACC)
>4 yo = Wong-Baker FACES
>10 yo = Visual analog scale, numeric pain scale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Normal lab values in children vs. adults

A

DIFFERENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BMI equation

A

[weight/(height^2)] x 10000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IBW equation

A

[(height^2) x 1.65]/1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bedside Schwartz

A

CrCl (mL/min/1.73m2) = (0.413 x height)/SCr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Challenges in Pediatric Pharmacotherapy

A

PK/PD differences
Psychosocial influences on drug therapy
Caregiver medication administration hesitance
Dosage formulation selections
Off-label medication use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many drugs are indicated to be used in pediatric patients?

A

1/4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Limitations to off-label drug usage

A

Potential for denied insurance provider coverage
Liability for adverse effects
Limited experience in specific conditions or age groups
Limited available dosage formulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Evidence considerations of off-label drug usage

A

Extrapolating adult data is not always accurate
Use guidelines when available
Use primary literature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Consequences of poor-/non-adherence

A

Delayed/absent clinical improvement
Worsening illness
unnecessary therapy modifications that can lead to adverse clinical outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Reasons for non-adherence

A

Apprehension regarding medication adverse effects
Caregiver inability or unavailability to administer drugs
Caregivers may be overwhelmed/confused
Inappropriate measurements of medication dose
Missed doses due to resistance from the child

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Strategies to improve adherence

A

Caregiver education should be reinforced at several points of healthcare visit
Ease of administration (palatable, lower frequency)
Decrease child resistance (reward systems, positive reinforcement)
Empowering older children/adolescents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dosage form considerations: Parenteral

A

Volume of IV fluids
Vehicle safety
IV access

17
Q

Dosage form considerations: Oral

A

Manufactured liquid preparations
Extemporaneously compounded liquid preparations
Volume of PO fluids
Chewable tablets
Tablets
Capsules
Granules

18
Q

Dosage form considerations: Palatability

A

Children have different preferences
Mixing with food (chocolate syrup, peanut butter, crystal lite, applesauce)
Flavoring (FlavoRx)

19
Q

Extemporaneous Preparation Resources

A

USP
Lexicomp: Pediatric & Neonatal Dosage Handbook
Micromedex
Pediatric Drug Formulations
Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

20
Q

When compounding/stability information is not available

A

USP: water containing formulations prepared from solid ingredients BUD no later than 14 days when stored between 2C-8C
Powder papers
Splitting/crushing tablets - ISMP do not crush list
Opening capsules
Injectable medications administered orally - OK if both oral and IV contain same salt form with similar bioavailability

21
Q

Determining Pediatric Drug Dosages

A

Commonly based on mg/kg/dose OR mg/kg/day
mg/m2
Max pediatric dose = adult dose
May also be based on gestational age, actual age, patient weight ranges

22
Q

Assessment of renal function

A

eGFR
Urine output
Ins = mL/kg/DAY
Outs = mL/kg/HOUR
Anuria = Zero output
Oliguria = <0.5-1 mL/kg/hour
Normal urine output = > 1 mL/kg/hour
Polyuria = > 4 mL/kg/hour

23
Q

Dosing reference

A

Preference Lexicomp or Micromedex